Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genflow Biosci (GENF) Share Price

Price 2.10p on 06-02-2026 at 19:40:06
Change -0.10p -4.55%
Buy 2.20p
Sell 2.00p
Last Trade: Unknown 184,192.00 at 2.10p
Day's Volume: 5,061,743
Last Close: 2.10p
Open: 2.20p
ISIN: GB00BP2C3V08
Day's Range 2.10p - 2.10p
52wk Range: 0.575p - 2.60p
Market Capitalisation: £10.36m
VWAP: 2.120835p
Shares in Issue: 493.55m

Genflow Biosci (GENF) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 184,192 2.10p Uncrossing Trade
16:35:18 - 06-Feb-26
Sell* 237,800 2.011p Ordinary
16:08:16 - 06-Feb-26
Buy* 90 2.20p Ordinary
15:42:18 - 06-Feb-26
Buy* 2,143 2.0895p Ordinary
15:27:01 - 06-Feb-26
Buy* 100,000 2.0895p Ordinary
15:24:33 - 06-Feb-26
Buy* 195,753 2.08p Ordinary
14:42:20 - 06-Feb-26
Unknown* 306,529 2.0699p Ordinary
14:41:42 - 06-Feb-26
Buy* 23,690 2.10p Ordinary
14:35:09 - 06-Feb-26
Buy* 23,690 2.10p Ordinary
14:35:09 - 06-Feb-26
Buy* 106 2.20p SI Trade
14:35:09 - 06-Feb-26
See more Genflow Biosci trades

Genflow Biosci (GENF) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Feb 2026 (Fri) 2.20 2.10 2.10 2.10 5,061,743
5th Feb 2026 (Thu) 2.20 2.20 2.20 2.20 9,400,897
4th Feb 2026 (Wed) 1.90 2.20 1.925 2.00 1,333,930
3rd Feb 2026 (Tue) 1.99 2.00 1.90 1.90 1,546,848
2nd Feb 2026 (Mon) 1.90 1.95 1.80 1.90 4,931,042
30th Jan 2026 (Fri) 1.90 1.945 1.945 1.945 889,034
29th Jan 2026 (Thu) 1.90 1.90 1.77 1.90 1,012,031
28th Jan 2026 (Wed) 2.05 2.05 1.90 1.90 820,410
27th Jan 2026 (Tue) 1.95 1.95 1.95 1.95 218,945
26th Jan 2026 (Mon) 1.85 1.95 1.85 1.95 1,821,530
23rd Jan 2026 (Fri) 1.90 1.90 1.85 1.85 1,792,846
22nd Jan 2026 (Thu) 2.00 2.00 1.90 1.90 2,237,157
21st Jan 2026 (Wed) 1.95 2.00 1.90 2.00 2,461,582
20th Jan 2026 (Tue) 1.95 1.95 1.90 1.95 1,155,188
19th Jan 2026 (Mon) 1.98 1.98 1.85 1.95 861,634
16th Jan 2026 (Fri) 1.85 1.99 1.85 1.85 716,549
15th Jan 2026 (Thu) 2.00 2.00 1.85 1.85 1,621,419
14th Jan 2026 (Wed) 2.00 2.10 2.00 2.00 3,182,281
13th Jan 2026 (Tue) 1.90 1.95 1.90 1.95 623,720
12th Jan 2026 (Mon) 1.825 2.00 1.825 1.90 4,791,398
9th Jan 2026 (Fri) 1.90 1.90 1.825 1.825 745,648
8th Jan 2026 (Thu) 1.95 1.95 1.80 1.90 1,506,862
7th Jan 2026 (Wed) 1.825 1.90 1.825 1.90 1,556,955
See more Genflow Biosci price history

Genflow Biosci (GENF) Regulatory News

Date Source Headline
30th Jan 2026 12:29 pm RNS Holding(s) in Company
28th Jan 2026 7:00 am RNS Administrative Approval of Grant & 2026 Priorities
19th Jan 2026 7:00 am RNS Directorate change
8th Jan 2026 7:00 am RNS-R Review of 2025
16th Dec 2025 7:00 am RNS Completion of Dosing Phase of Canine Gene Therapy
11th Dec 2025 7:00 am RNS-R Genflow to Attend Healthcare Conference
31st Oct 2025 7:00 am RNS Total Voting Rights
24th Oct 2025 7:00 am RNS Holding(s) in Company
22nd Oct 2025 7:00 am RNS Second European Patent Application
20th Oct 2025 7:00 am RNS Recognition of Patentability of Claims
See more Genflow Biosci regulatory news

Genflow Biosci (GENF) Share News

EXECUTIVE CHANGES: Genflow Biosciences names Berdugo as new chair

19th Jan 2026 14:32

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: Genflow Biosciences lays out hopes for 2026

8th Jan 2026 21:10

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Genflow patent progress; Accsys new debt facilities

22nd Oct 2025 22:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Genflow Biosciences says European patent publication is "step forward"

20th Oct 2025 14:07

(Alliance News) - Genflow Biosciences PLC on Monday reported progress towards full protection of its longevity gene therapy platform. Read More

Genflow Biosciences hails data from trial of dog ageing gene therapy

10th Oct 2025 11:41

(Alliance News) - Genflow Biosciences PLC on Friday reported strong data from a proof-of-concept clinical trial of its proprietary SIRT6-centenarian gene therapy for age-related decline in elderly dogs. Read More

See more Genflow Biosci news
FTSE 100 Latest
Value10,369.75
Change60.53

Login to your account

Forgot Password?

Not Registered